HeartSciences Inc. says it got the green light from the FDA for its MyoVista® wavECG TM device.

Oct 6, 2026, 4:48 PM ETTrialRead the original at SEC EDGAR

Good for HSCS

HeartSciences received FDA clearance for its MyoVista heart-testing device, removing a regulatory hurdle. Sales are not reported, and its proposed merger still needs shareholder approval and could fail.

HSCS · HeartSciences Inc.

AI read · Good for HSCS

The AI's read

This clears an important regulatory hurdle for the device. The report does not say whether sales have begun or how many customers may use it. The proposed merger is still pending, and shareholder approval is one condition to completing it.

Get alerts for HSCS

Follow HeartSciences Inc. (HSCS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HSCS

Free on the App Store and Google Play, or on the web.